How symptom questionnaires (OSDI, SPEED) inform diagnosis and treatment
Why We Use Symptom Questionnaires
Symptom questionnaires capture how often your eyes bother you and how much those symptoms affect your daily activities. They record details about dryness, burning, grittiness, light sensitivity, and blurry vision. By scoring your responses, we can see whether your symptoms are mild, moderate, or severe.
These tools also help us track patterns over time and compare your progress after starting treatment. Questionnaires turn your personal experience into numbers that we can measure and monitor.
Clinical tests show us what is happening on the surface of your eye, but they do not always reflect how you feel. You might have mild findings on a test yet experience significant discomfort, or the reverse. Your subjective report fills in the gaps and ensures we treat the whole person, not just the test results.
We value your experience because symptoms guide treatment choices. Two patients with identical test findings may need different therapies based on how much their eyes bother them every day.
We most often use questionnaires to evaluate dry eye disease and other ocular surface disorders. These include meibomian gland dysfunction, blepharitis, and inflammatory conditions that affect the tear film. Questionnaires can also help us assess how contact lenses or environmental factors impact your comfort.
In some cases, we use them to monitor recovery after eye surgery or to screen for chronic issues that might not show obvious signs during a brief exam.
We may ask you to complete a questionnaire at your first visit if you mention eye discomfort, irritation, or fluctuating vision. We also use them during follow-up appointments to see if your symptoms are improving. If you wear contact lenses or have a history of dry eye, we often include a questionnaire as part of routine screening.
Some insurance plans require documented symptom scores before approving certain treatments, so we incorporate questionnaires into our standard workflow to support your care.
The Main Questionnaires: OSDI and SPEED
The OSDI is one of the most widely used questionnaires in eye care. It includes twelve questions that ask about your symptoms and how they limit activities like reading, driving at night, or using a computer. Each question offers several answer choices, and we calculate a total score from zero to one hundred.
Higher scores indicate more severe symptoms. A score of 33 or higher indicates severe ocular surface disease.
The OSDI focuses on three main areas: your eye symptoms in the past week, how much those symptoms interfere with vision-related tasks, and whether environmental triggers make your eyes worse. It asks about sensitivity to light, grittiness, painful or sore eyes, and blurred vision.
- Frequency of symptoms like dryness, burning, and light sensitivity
- Difficulty with reading, driving, or computer work
- Reactions to wind, low humidity, or air-conditioned spaces
- Overall impact on your quality of life
The SPEED questionnaire is shorter and faster to complete than the OSDI. It includes eight questions that rate both the frequency and severity of common dry eye symptoms. You mark how often you experience dryness, grittiness, soreness, or burning, and then rate how bothersome each symptom is.
SPEED produces a total score from 0 to 28 by combining frequency and severity ratings. Typical cut points are 0 to 9 mild or asymptomatic, 10 to 19 moderate, and 20 to 28 severe.
SPEED emphasizes recent symptoms and also captures a longer recall window, which makes it useful for both screening and monitoring.
Both questionnaires assess dry eye symptoms, but the OSDI explores how symptoms affect your daily tasks, while SPEED focuses on symptom frequency and severity without as much detail on functional impact. The OSDI takes a bit longer to complete but provides a broader picture of how your eyes influence your life.
We choose between them based on your specific situation, the time available, and whether we need detailed functional information or a quick screening score. OSDI uses a 7 day recall period, while SPEED emphasizes current symptoms along with a longer recall window.
Besides OSDI and SPEED, other questionnaires exist for specialized needs. Some focus on contact lens discomfort, while others target specific symptoms like mucus discharge or eyelid inflammation. In research settings or complex cases, we may use more detailed tools.
For most patients, OSDI and SPEED give us a reliable symptom snapshot. In selected cases we use other validated tools such as DEQ-5, SANDE, CLDEQ-8 for contact lens wearers, or OPAS for ocular pain. We use validated wording and translations and keep the recall window consistent across visits. Contact lens specific tools such as CLDEQ-8 can better capture lens-related discomfort.
What to Expect When Taking a Questionnaire
You will usually fill out the questionnaire in the waiting room before your exam or on a tablet in the exam lane. Some offices send electronic versions by email or patient portal so you can complete them at home before your appointment. This saves time and lets you answer thoughtfully without feeling rushed.
If you arrive early, front desk staff may hand you a paper form along with your routine intake paperwork. We can provide validated translations or assistance if you need help completing the form.
Most questionnaires take between two and five minutes to finish. The SPEED form is generally quicker, while the OSDI may take a bit longer because it includes more questions about specific activities. You do not need to study or prepare in advance.
If you have questions about any item, you can ask our staff for clarification. We want your answers to be accurate and reflect your true experience.
Think about the past week or the time frame mentioned in the instructions. Try to give an honest average rather than focusing only on your best or worst day. If a question does not apply to you, most forms include a not applicable option.
- Answer based on your typical experience, not just today
- Be honest even if you think your symptoms sound minor
- Do not skip questions unless the form allows it
- Ask for help if any wording is confusing
- If English is not your preferred language, ask for a validated translated form or an interpreter
Use the same recall time frame at follow-up visits so scores remain comparable.
Once you hand in the form or submit it electronically, our team calculates your score. We review the results before or during your exam and combine them with other findings like tear tests and slit lamp examination. Your symptom score becomes part of your medical record and helps us explain our diagnosis and treatment plan.
If your score indicates significant symptoms, we may recommend additional testing or begin therapy right away.
How Your Scores Guide Diagnosis and Treatment
Your questionnaire generates a number that falls into a category such as normal, mild, moderate, or severe. For the OSDI, scores from zero to twelve are considered normal, thirteen to twenty-two are mild, twenty-three to thirty-two are moderate, and thirty-three or higher are severe. SPEED uses a different scale, but the principle is the same.
- OSDI: 0 to 12 normal, 13 to 22 mild, 23 to 32 moderate, 33 to 100 severe
- SPEED: 0 to 9 mild or asymptomatic, 10 to 19 moderate, 20 to 28 severe
- Scores are one part of the overall picture and are interpreted with your exam findings
We look for changes that are larger than normal day to day variability to judge whether treatment is helping. We explain your score in simple terms and show you where you fall on the spectrum. This helps you understand the severity of your condition and why certain treatments are appropriate.
If your score falls in the mild range, we typically start with basic therapies at home. These include preservative-free artificial tears, warm compresses, eyelid hygiene, and lifestyle changes like taking screen breaks or using a humidifier. We also discuss environmental triggers and recommend ways to reduce exposure. If you need drops more than 4 times per day, we recommend preservative-free formulations to reduce irritation.
Many patients notice improvement, but timelines vary based on the cause of dryness and adherence.
Moderate or severe scores often prompt us to consider additional therapies tailored to your findings. Options can include prescription drops such as cyclosporine or lifitegrast, perfluorohexyloctane for evaporative disease, short courses of topical corticosteroids for flares, varenicline nasal spray, punctal plugs after surface inflammation is controlled, oral doxycycline or azithromycin for meibomian gland dysfunction, autologous serum or platelet rich plasma tears, amniotic membrane for persistent epithelial disease, scleral lenses for severe surface disease, and in-office procedures such as meibomian gland expression, thermal pulsation, or intense pulsed light.
We review benefits and risks. For example, topical steroids can raise eye pressure or accelerate cataract formation, tetracyclines are avoided in pregnancy and children, and intense pulsed light is not suitable for all skin types or for patients on photosensitizing medications.
Questionnaires never stand alone. We pair your symptom score with objective measures such as fluorescein tear breakup time, corneal and conjunctival staining with fluorescein or lissamine green, Schirmer testing or phenol red thread, tear osmolarity, MMP-9 testing, meibography, blink assessment and contact lens fit evaluation when relevant. If your symptoms are severe but tests appear normal, we look for other causes like nerve sensitivity or underlying inflammation. If tests show severe disease but symptoms are mild, we still treat the findings to protect the ocular surface and reduce complications. If symptoms are severe with minimal clinical signs, we consider neuropathic ocular pain and may adjust evaluation accordingly.
This combined approach ensures we address both what we see and what you feel.
Very high symptom scores, especially if accompanied by severe pain, sudden vision changes, or discharge, may signal an urgent problem such as infection, corneal ulcer, or severe inflammation.
- Chemical exposure or trauma
- Contact lens wear with severe pain, redness, and light sensitivity
- Rapid onset of significant vision loss
If you wear contact lenses and develop severe pain or redness, remove the lenses and contact us immediately. In those situations, we aim to arrange same day or next day evaluation and begin appropriate treatment promptly. If you experience sudden severe symptoms between visits, contact our office right away rather than waiting for your next scheduled questionnaire.
Your safety and vision come first, and we adjust our schedule to accommodate urgent needs.
Tracking and Follow-Up Questionnaires
Repeating the same questionnaire after starting treatment shows us whether your symptoms are improving, staying the same, or getting worse. A drop in your score tells us the therapy is working, while a steady or rising score means we need to adjust your plan. Tracking changes over months or years also helps us catch flare-ups early.
Consistent monitoring ensures we do not miss subtle shifts that you might not notice day to day.
The frequency depends on your condition and treatment. For active dry eye disease, we may ask you to complete a questionnaire at every visit, which could be every few weeks at first. Once your symptoms stabilize, we switch to every few months or annually. Patients with chronic conditions often fill out a questionnaire once or twice a year as part of routine care.
We communicate the schedule clearly so you know what to expect.
Some patients find it helpful to keep a simple symptom diary at home, noting days when discomfort is worse or better. You can share this information at follow-up appointments to give us a fuller picture. While informal tracking is optional, it can reveal patterns related to weather, activity, or medication use.
We encourage you to reach out between visits if symptoms change dramatically or new issues arise.
We look for meaningful changes rather than small day to day fluctuations. A significant drop in your score, such as moving from severe to moderate or moderate to mild, indicates meaningful improvement. Small fluctuations of a few points are normal and may reflect daily variations. If your score improves but then plateaus, we explore whether additional treatments or lifestyle adjustments might help you reach your goal.
- Decreasing scores suggest successful treatment
- Stable scores may mean you need a different approach
- Rising scores signal the need for urgent reassessment
- Sudden jumps often point to flare-ups or new triggers
We use follow-up scores to decide whether to continue, modify, or escalate treatment. If your symptoms resolve and scores stay low, we may reduce the intensity of therapy or switch to maintenance care. If scores remain high despite treatment, we add new therapies, refer you to a specialist, or investigate underlying causes like autoimmune disease.
Your evolving symptom picture guides every decision we make about your care plan.
Frequently Asked Questions
Yes, some patients have significant ocular surface damage or other eye conditions without reporting many symptoms, especially in early stages or if nerves are less sensitive. We always perform clinical tests alongside questionnaires to catch disease that might not cause discomfort yet.
Questionnaires use standardized wording that might not capture your exact experience. If the score seems too low, tell our eye doctor during your exam so we can explore additional questions or use a different assessment tool. Your verbal description is just as important as the number.
Absolutely. Questionnaires focus on common dry eye symptoms, but you may experience flashes, floaters, redness, or other issues that deserve attention. Always bring up anything unusual, even if it was not addressed in the form.
No. They complement clinical tests but do not replace them. We need objective measurements of tear film, gland function, and corneal health to make a complete diagnosis. Questionnaires tell us how you feel, while tests show us what is happening on the ocular surface.
Many payers require documentation of symptom severity, objective test findings, and prior conservative therapy before covering advanced dry eye treatments. Requirements vary by carrier and therapy. Our billing team can review your specific plan.
If you realize immediately that you misunderstood a question or marked the wrong box, let us know before your exam and we can give you a fresh form. Once we have calculated the score and started your visit, we typically wait until the next appointment to reassess rather than retake the same questionnaire on the same day.
Getting help for dry eye and ocular surface symptoms
If you are experiencing ongoing eye discomfort, dryness, or vision changes, schedule an appointment so we can perform a comprehensive evaluation. This includes a symptom questionnaire and clinical testing. Early assessment helps us tailor a treatment plan that fits your needs.